Vimarsana
Biggest News Aggregation in the World

Cipla Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cipla Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cipla Inc Today - Breaking & Trending Today

Over-the-Counter (OTC) Analgesics Market size is set to grow by USD 7.20 billion from 2024-2028, Growing aging population globally boost the market, Technavio - Vimarsana News

Over-the-Counter (OTC) Analgesics Market size is set to grow by USD 7.20 billion from 2024-2028, Growing aging population globally boost the market, Technavio

/PRNewswire/ -- The global over-the-counter (OTC) analgesics market size is estimated to grow by USD 7.20 billion from 2024-2028, according to Technavio. The...

Paracetamol Market size is set to grow by USD 929.4 million from 2024-2028, Significant use of paracetamol as API in large number of OTC drugs to boost the market growth, Technavio - Vimarsana News

Paracetamol Market size is set to grow by USD 929.4 million from 2024-2028, Significant use of paracetamol as API in large number of OTC drugs to boost the market growth, Technavio

/PRNewswire/ -- The global paracetamol market size is estimated to grow by USD 929.4 million from 2024-2028, according to Technavio. The market is estimated to...

Gonorrhea Therapeutics Market size is set to grow by USD 541.5 million from 2024-2028, Rising prevalence of gonorrhea boost the market, Technavio - Vimarsana News

Gonorrhea Therapeutics Market size is set to grow by USD 541.5 million from 2024-2028, Rising prevalence of gonorrhea boost the market, Technavio

/PRNewswire/ -- The global gonorrhea therapeutics market size is estimated to grow by USD 541.5 billion from 2024-2028, according to Technavio. The market is...

Liposomal Doxorubicin Market to Grow at 6.7% CAGR, Reaching USD 2.3 Billion by 2033 - Vimarsana News

Liposomal Doxorubicin Market to Grow at 6.7% CAGR, Reaching USD 2.3 Billion by 2033

Market OverviewThe Global Liposomal Doxorubicin Market is projected to witness significant growth over the next decade. Valued at USD 1.2 billion in 2023, the market is expected to reach approximately USD 2.3 billion by 2033, reflecting a compound annual growth rate (CAGR) of 6.7% from 2024 to 2033. This growth can...

Coherent Market Insights: Global Non Opioid Pain Treatment Market Size to Worth USD 140.56 Bn By 2031 - Vimarsana News

Coherent Market Insights: Global Non Opioid Pain Treatment Market Size to Worth USD 140.56 Bn By 2031

BURLINGAME, Calif., May 22, 2024 /PRNewswire/ -- The global Non Opioid Pain Treatment Market is projected to grow from USD 78.89 billion in 2024, and it is projected to reach USD 140.56 billion